These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3546243)

  • 1. Evaluation of aztreonam, cefoperazone, latamoxef and ceftazidime in the hamster colitis model.
    Weinberg DS; Fernandes PB; Kao CC; Clark JM; Bonner DP; Sykes RB
    J Antimicrob Chemother; 1986 Dec; 18(6):729-45. PubMed ID: 3546243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies with temocillin in the hamster model of antibiotic-associated colitis.
    Boon RJ; Beale AS
    Drugs; 1985; 29 Suppl 5():57-63. PubMed ID: 4029030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clostridium difficile--a spectrum of virulence and analysis of putative virulence determinants in the hamster model of antibiotic-associated colitis.
    Borriello SP; Ketley JM; Mitchell TJ; Barclay FE; Welch AR; Price AB; Stephen J
    J Med Microbiol; 1987 Aug; 24(1):53-64. PubMed ID: 3612744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of therapy with latamoxef (moxalactam) on carriage of Clostridium difficile.
    Deery HG; Jones PG; Kauffman CA; Fekety R; Silva J; Sell TL; Supena RB
    J Antimicrob Chemother; 1984 May; 13(5):521-4. PubMed ID: 6735965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in vitro antibacterial activity of aztreonam against clinical isolates of gram-negative bacteria.
    Shibl AM; Ishag AH; Durgham SM
    Chemotherapy; 1989; 35 Suppl 1():72-6. PubMed ID: 2659292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inciting and etiologic agents of colitis.
    Silva J; Fekety R; Werk C; Ebright J; Cudmore M; Batts D; Syrjamaki C; Lukens J
    Rev Infect Dis; 1984; 6 Suppl 1():S214-21. PubMed ID: 6718935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oritavancin does not induce Clostridium difficile germination and toxin production in hamsters or a human gut model.
    Freeman J; Marquis M; Crowther GS; Todhunter SL; Fawley WN; Chilton CH; Moeck G; Lehoux D; Wilcox MH
    J Antimicrob Chemother; 2012 Dec; 67(12):2919-26. PubMed ID: 22899803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies with temocillin in a hamster model of antibiotic-associated colitis.
    Boon RJ; Beale AS
    Antimicrob Agents Chemother; 1985 Jun; 27(6):980-1. PubMed ID: 3875312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of eight cephalosporins in hamster colitis model.
    Ebright JR; Fekety R; Silva J; Wilson KH
    Antimicrob Agents Chemother; 1981 Jun; 19(6):980-6. PubMed ID: 6973951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of yogurt on clindamycin-induced Clostridium difficile colitis in hamsters.
    Kotz CM; Peterson LR; Moody JA; Savaiano DA; Levitt MD
    Dig Dis Sci; 1992 Jan; 37(1):129-32. PubMed ID: 1728517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clindamycin-induced colitis.
    Fekety R; Silva J; Browne RA; Rifkin GD; Ebright JR
    Am J Clin Nutr; 1979 Jan; 32(1):244-50. PubMed ID: 760500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the efficacy of ramoplanin and vancomycin in both in vitro and in vivo models of clindamycin-induced Clostridium difficile infection.
    Freeman J; Baines SD; Jabes D; Wilcox MH
    J Antimicrob Chemother; 2005 Oct; 56(4):717-25. PubMed ID: 16143709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of clindamycin-induced colitis in hamsters by Clostridium sordellii antitoxin.
    Allo M; Silva J; Fekety R; Rifkin GD; Waskin H
    Gastroenterology; 1979 Feb; 76(2):351-5. PubMed ID: 759263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of clindamycin and clindamycin metabolites in the hamster model of antibiotic-associated colitis.
    Onderdonk AB; Brodasky TF; Bannister B
    J Antimicrob Chemother; 1981 Nov; 8(5):383-93. PubMed ID: 7319980
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of antibiotic treatment on growth of and toxin production by Clostridium difficile in the cecal contents of mice.
    Pultz NJ; Donskey CJ
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3529-32. PubMed ID: 16048976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro and in-vivo characterisation of resistance to colonisation with Clostridium difficile.
    Larson HE; Welch A
    J Med Microbiol; 1993 Feb; 38(2):103-8. PubMed ID: 8429534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gnotobiotic models for study of the microbial ecology of Clostridium difficile and Escherichia coli.
    Wilson KH; Sheagren JN; Freter R; Weatherbee L; Lyerly D
    J Infect Dis; 1986 Mar; 153(3):547-51. PubMed ID: 3512730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transfer of the cecal flora of the hamster to the germfree C3H mouse: use of this model to study the flora of the anti-Clostridium difficile barrier].
    Su WJ; Bourlioux P; Bournaud M; Besnier MO; Fourniat J
    Can J Microbiol; 1986 Feb; 32(2):132-6. PubMed ID: 3516351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal damage mediated by clostridial toxin in experimental clindamycin-associated colitis.
    Abrams GD; Allo M; Rifkin GD; Fekety R; Silva J
    Gut; 1980 Jun; 21(6):493-9. PubMed ID: 6776012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clostridial typhlitis associated with topical antibiotic therapy in a Syrian hamster.
    Alworth L; Simmons J; Franklin C; Fish R
    Lab Anim; 2009 Jul; 43(3):304-9. PubMed ID: 19116288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.